title: Hepatitis B surface antigen clearance in lamivudine-treated patients: main therapeutic goal?
authors.forename: Teresa
authors.initials: T
authors.lastname: Santantonio
authors.forename: Massimo
authors.initials: M
authors.lastname: Fasano
authors.forename: Stefania
authors.initials: S
authors.lastname: Palattella
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Pastore
mesh_terms: D006514:Hepatitis B Surface Antigens / Q000097:blood*; D019694:Hepatitis B, Chronic / Q000188:drug therapy* / Q000276:immunology*; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use*; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*
chemical_list: D006514:Hepatitis B Surface Antigens; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine